Biotechnology
Deval Patrick’s Ties to Health-Care Industry Could be a Liability
DEVAL PATRICK’S TIES to health-care and drug companies could make him a punching bag for Democratic candidates who support single-payer health care and criticize the pharmaceutical industry. Since leaving the governorship of Massachusetts in 2015, Patrick has served on the boards of American Well Corp., a telemedicine company, and Global Blood Therapeutics, a pharmaceutical firm. …
GetInsured Successfully Upgrades Technology for Minnesota’s Health Insurance Exchange
MOUNTAIN VIEW, Calif., Nov. 4, 2019 /PRNewswire/ — GetInsured, a health insurance marketplace platforms provider, partnered with MNsure, Minnesota’s health insurance exchange, and Minnesota IT Services, to upgrade MNsure’s enrollment and back-end record-keeping functionality, as well as improve data transfers between MNsure and insurance carriers. The window to decide on health insurance in Minnesota will …
Cross-industrial technologies make a splash in Asia Agri-Tech Expo in Taipei
The rising awareness of food safety has triggered a rush for organic products and perked up the business opportunity of greenhouse farming. “Fast growth, fast delivery, fast to market and farming in all seasons are the strengths of indoor farming. These advantages rely on cross-industrial technologies which solve all kinds of solutions from food production, harvest, …
Death toll climbs from vaping illnesses as Florida, Georgia report new fatalities
A man vapes at a store on September 17, 2019 in New York City. Spencer Platt | Getty Images Georgia and Florida health officials have both reported their first vaping-related deaths, bringing the total number of U.S. fatalities from a lung disease that resembles a rare form of pneumonia to at least 11. Georgia is …
How to Invest in MRNA Technology
Text size Courtesy of Translate For investors, there are a handful of ways to get comfortable with a gamble on mRNA. The strongest endorsement of Moderna (ticker: MRNA) and Translate Bio (TBIO) may have come from Big Pharma. AstraZeneca (AZN) is among the largest shareholders of Moderna, with a 7.7% stake, and has three separate …
A new path to cancer therapy: developing simultaneous multiplexed gene editing technology
Dr. Mihue Jang and her group at the Center for Theragnosis of the Korea Institute of Science and Technology (KIST, President Byung-gwon Lee) announced that they have developed a new gene editing system that could be used for anticancer immunotherapy through the simultaneous suppression of proteins that interfere with the immune system expressed on the …
Rapid DNA testing market takes off as Kentucky police test new technology
In this photo taken November 16, 2018, Stephen Meer, chief information officer from ANDE, demonstrates in Chico, Calif., his company’s Rapid DNA analysis system, which is being used to try to ID victims of the Northern California wildfire. Sudhin Thanawala | AP The Kentucky State Police started using a new DNA test in February that …
AbbVie Strikes Deal to Buy Allergan for About $63 Billion
Botox maker Allergan has a market capitalization of $42.47 billion, based on Monday’s close, according to FactSet. Photo: Richard Drew/Associated Press Updated June 25, 2019 7:04 am ET AbbVie Inc. ABBV -0.42% has reached a deal to buy Allergan AGN -0.95% PLC for about $63 billion, as two big drugmakers bet a combination will deliver …
PwC says US companies expected to spend 6% more on health care next year
A pharmacist fills out prescription in New York City. Yvonne Hemsey | Hulton Archive | Getty Images The presidential hopefuls aren’t the only ones eyeing health care issues for 2020. Large employers are putting together benefit plans for next year, and they are expecting the rise in employee health costs to hit a four-year high, …
BGI Group Introduces New Technology Standard and Cost-Effective Solution for High Quality Haplotype-phased De Novo Human Genome Assembly
The new BGI standard 676 Quality Genome helps deliver on the promise of personalized medicine by providing more accurate and comprehensive genetic predictions, since it assembles each person’s genome individually and is not dependent on a reference genome, said Rade Drmanac, MGI Chief Scientific Officer, who presented the specifications during a talk at the European …
